Effect of a Cepham Supplement on Hot Flashes and Menopausal Symptoms in Postmenopausal Women

Launched by JACKSONVILLE UNIVERSITY · Apr 18, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at whether a daily nutritional supplement can help reduce hot flashes and other uncomfortable symptoms that many women experience after menopause. The researchers want to find out if this supplement can lower the number and severity of hot flashes and improve overall menopausal symptoms. To do this, some participants will take the actual supplement, while others will take a placebo, which looks the same but has no active ingredients.

Women between the ages of 40 and 60 who have been postmenopausal for at least a year and are dealing with bothersome hot flashes may be eligible to participate. Those who join the study will take the supplement or placebo daily for 30 days and will keep track of their hot flashes using a short online survey. They will also fill out a questionnaire about their symptoms at the beginning and end of the study. It's important to note that women currently using hormone therapy or certain medications affecting hot flashes, as well as those with significant health issues, will not be able to participate.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Adult women aged 40-60 years.
• • Menopause Rating Scale score: (a) GE 14 and (b) score of 3 or 4 (severe to very severe) for hot flashes (Blumel et al., 2018).
• Exclusion Criteria:
• • Current use of hormone therapy or other medications known to affect hot flashes.
• • Significant comorbidities that may interfere with study participation.